Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing Of CBD Lines Of Tinctures, Oils, Creams And More
The cannabis CBD industry sees a bright future of reaching $30 billion at retail by 2023, as reported by Digital Privacy News and Bloomberg from research by Marijuana Business Daily. Medical cannabis is now legalized in 33 states — with five others having votes on legal cannabis next month. Succeeding in this booming market is Can B Corp. (OTCQB: CANB) with its diverse marketing strategy. This health and wellness emerging growth company offers lines of hemp derived CBD, CBD and non-CBD products under license for the Lifeguard® lifestyle brand, Canbiola branded products through physicians and products through white label and private label plus other subsidiaries.
The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), Charlotte’s Web (CSE: CWEB), INSYS Therapeutics, Inc. (NASDAQ: INSY), cbdMD (NYSE: YCBD), Joy Organics (NASDAQ: JOYG),, GW Pharmaceuticals (NASDAQ: GWPH) and Supreme Cannabis Co. (OTC: SPRWF).
Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing Of CBD Lines Of Tinctures, Oils, Creams And More
Cannabis is anticipating long-term growth through its widespread acceptance, legalization in more states in the U.S. and growing acceptance of CBD. Cannabis is sold online, at mainstream retailers and is available as medical CBD prescribed by physicians. State-by-state differ regarding cannabis sales under COVID-19 restrictions, but a report by site Real Money finds that analysts say a lifting of state economies is reflected in the beginning of an improvement in cannabis sales. Long term, CBD is seen as having marked growth. Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing Of CBD Lines Of Tinctures, Oils, Creams And More.
Diverse Marketing Strategies For Proprietary And Licensed Brands
At Can B Corp. (OTCQB: CANB), a broad assortment of hemp-derived CBD lines have optimistic futures because of the company’s diverse marketing strategies: proprietary licensed brands, white labels, private labels through third parties and distribution through various channels such as retail, professional (physician), direct sales through its website and sales through subsidiaries. This health and wellness firm is an emerging growth company. Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing CBD Lines Of Tinctures, Oils, Creams And More.
It markets products such as drops/tinctures, oils, creams, moisturizers, chews, isolate, gel caps, concentrates and more. Its diverse proprietary product lines are available under license, private label and branded labels. Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing Of CBD Lines Of Tinctures, Oils, Creams And More.
Marco Alfonsi, CAN B’s Chief Executive Officer, said, “Our pipeline of opportunities remains strong highlighted by our exclusive license agreement with Lifeguard Licensing Corp. for the use of the well known LifeGuard brand name and logo for a host of products that will include CBD and non-CBD formulations and our Can B Superfood line. Our team also remains focused on expanding the availability of our Pure Leaf Oil and Canbiola CBD brands, as exemplified by our recent agreement with United Grocery Outlets.”
Can B Corp. (OTCQB: CANB) Provides CBD Products Under Multi-Channels
Can B Corp. (OTCQB: CANB) is a health and wellness company providing CBD products under the brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It markets to multi-channels including medical offices, doctor’s offices, retailers, online and direct.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press
